32 LUX-Lung 3: Symptom and health-related quality of life results from a randomized phase III study in 1st-line advanced NSCLC patients harbouring EGFR mutations
O'Byrne, K.J., Sequist, L.V., Schuler, M., Yamamoto, N., Hirsh, V., Mok, T., Lungershausen, J., Shahidi, M., Palmer, M., Yang, J.C.-H.Volume:
79
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(13)70032-1
Date:
January, 2013
File:
PDF, 45 KB
english, 2013